Commercial Head of Injectables and Health Security for Kindeva Drug Delivery talks about the Bridgeton, Missouri aseptic injectable fill-finish facility.
Consortium between Wacker and CordenPharma entered the pandemic readiness state as of June 1 to produce 80 million vaccine doses within a short time, if needed.
Annex 1-compliant production cell with gloveless isolator and integrated air treatment is designed to offer new technological advances in aseptic filling.